Literature DB >> 26519139

The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.

William E Van Nostrand1.   

Abstract

Ischemic and hemorrhagic strokes are a significant cause of brain injury leading to vascular cognitive impairment and dementia (VCID). These deleterious events largely result from disruption of cerebral hemostasis, a well-controlled and delicate balance between thrombotic and fibrinolytic pathways in cerebral blood vessels and surrounding brain tissue. Ischemia and hemorrhage are both commonly associated with cerebrovascular deposition of amyloid ß-protein (Aß). In this regard, Aß directly and indirectly modulates cerebral thrombosis and fibrinolysis. Further, major isoforms of the Aß precursor protein (AßPP) function as a potent inhibitor of pro-thrombotic proteinases. The purpose of this review article is to summarize recent research on how cerebral vascular Aß and AßPP influence cerebral hemostasis. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia, edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid ß-protein; Amyloid ß-protein precursor; Cerebral amyloid angiopathy; Cerebral hemostasis; Hemorrhage; Ischemia; Proteinase inhibition

Mesh:

Substances:

Year:  2015        PMID: 26519139      PMCID: PMC4821744          DOI: 10.1016/j.bbadis.2015.10.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  176 in total

Review 1.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain.

Authors:  H Ishii; H H Salem; C E Bell; E A Laposata; P W Majerus
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

Review 3.  Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis.

Authors:  M F B G Gebbink
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

4.  Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles.

Authors:  R Natté; M L Maat-Schieman; J Haan; M Bornebroek; R A Roos; S G van Duinen
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

5.  Hereditary cerebral hemorrhage with amyloidosis-Dutch type: better correlation of cognitive deterioration with advancing age than with number of focal lesions or white matter hyperintensities.

Authors:  M Bornebroek; M A Van Buchem; J Haan; R Brand; J B Lanser; F T de Bruïne; R A Roos
Journal:  Alzheimer Dis Assoc Disord       Date:  1996       Impact factor: 2.703

6.  Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.

Authors:  S G van Duinen; E M Castaño; F Prelli; G T Bots; W Luyendijk; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Differential regional and cellular distribution of beta-amyloid precursor protein messenger RNAs containing and lacking the Kunitz protease inhibitor domain in the brain of human, rat and mouse.

Authors:  C Solà; G Mengod; A Probst; J M Palacios
Journal:  Neuroscience       Date:  1993-03       Impact factor: 3.590

8.  Spontaneous intracerebral hemorrhage and liver dysfunction.

Authors:  H Niizuma; J Suzuki; T Yonemitsu; T Otsuki
Journal:  Stroke       Date:  1988-07       Impact factor: 7.914

Review 9.  Brain regulation of thrombosis and hemostasis: from theory to practice.

Authors:  Mark J Fisher
Journal:  Stroke       Date:  2013-10-01       Impact factor: 7.914

10.  Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.

Authors:  Justin Paul; Sidney Strickland; Jerry P Melchor
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  8 in total

1.  Relationship between β-amyloid protein 1-42, thyroid hormone levels and the risk of cognitive impairment after ischemic stroke.

Authors:  Lei Mao; Xiao-Han Chen; Jian-Hua Zhuang; Peng Li; Yi-Xin Xu; Yu-Chen Zhao; Yue-Jin Ma; Bin He; You Yin
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

2.  Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.

Authors:  Hedok Lee; Feng Xu; Xiaodan Liu; Sunil Koundal; Xiaoyue Zhu; Judianne Davis; David Yanez; Joseph Schrader; Aleksandra Stanisavljevic; Douglas L Rothman; Joanna Wardlaw; William E Van Nostrand; Helene Benveniste
Journal:  J Cereb Blood Flow Metab       Date:  2020-08-13       Impact factor: 6.200

3.  Data on thrombotic ischemic lesions in the presence or absence of amyloid ß-protein precursor or its homolog amyloid precursor-like protein-2 in mice.

Authors:  Feng Xu; William E Van Nostrand
Journal:  Data Brief       Date:  2015-12-03

Review 4.  Amyloidosis in Retinal Neurodegenerative Diseases.

Authors:  Ambra Masuzzo; Virginie Dinet; Chelsea Cavanagh; Frederic Mascarelli; Slavica Krantic
Journal:  Front Neurol       Date:  2016-08-08       Impact factor: 4.003

Review 5.  APP as a Protective Factor in Acute Neuronal Insults.

Authors:  Dimitri Hefter; Andreas Draguhn
Journal:  Front Mol Neurosci       Date:  2017-02-02       Impact factor: 5.639

Review 6.  Association of Blood Amyloid Beta-Protein 1-42 with Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Hui Chen; Sichun Gu; Xiaoying Liu; Anjie Xie; Changde Wang
Journal:  Biomed Res Int       Date:  2022-03-30       Impact factor: 3.411

Review 7.  Functional Reciprocity of Amyloids and Antimicrobial Peptides: Rethinking the Role of Supramolecular Assembly in Host Defense, Immune Activation, and Inflammation.

Authors:  Ernest Y Lee; Yashes Srinivasan; Jaime de Anda; Lauren K Nicastro; Çagla Tükel; Gerard C L Wong
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

8.  Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta-analyses.

Authors:  Falah Alhajraf; Deborah Ness; Abdul Hye; Andre Strydom
Journal:  Dev Neurobiol       Date:  2019-09-11       Impact factor: 3.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.